chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Nausea, Pain in extremity
Clinical narrative: itchiness at injection site; big red area in a weird shape at injection site; warm to touch at injection site; bad headache; very tired; nausea; not feeling like myself; possible low-grade fever; worsening soreness and pain at injection site; arm felt a little sore, as the night went on my harm was becoming more and more painful; didn't sleep well; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm felt a little sore, as the night went on my harm was becoming more and more painful), SLEEP DISORDER (didn't sleep well), HEADACHE (bad headache), FATIGUE (very tired) and NAUSEA (nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm felt a little sore, as the night went on my harm was becoming more and more painful), SLEEP DISORDER (didn't sleep well) and VACCINATION SITE DISCOMFORT (worsening soreness and pain at injection site). On 12-Jan-2021, the patient experienced HEADACHE (bad headache), FATIGUE (very tired), NAUSEA (nausea), FEELING ABNORMAL (not feeling like myself) and PYREXIA (possible low-grade fever). On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (big red area in a weird shape at injection site) and VACCINATION SITE WARMTH (warm to touch at injection site). On 12-Jan-2021, PYREXIA (possible low-grade fever) had resolved. On 13-Jan-2021, FATIGUE (very tired), NAUSEA (nausea) and FEELING ABNORMAL (not feeling like myself) had resolved. At the time of the report, PAIN IN EXTREMITY (arm felt a little sore, as the night went on my harm was becoming more and more painful), SLEEP DISORDER (didn't sleep well), HEADACHE (bad headache), VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (big red area in a weird shape at injection site), VACCINATION SITE WARMTH (warm to touch at injection site) and VACCINATION SITE DISCOMFORT (worsening soreness and pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Sleep disorder, Vaccination site discomfort, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: itchiness at injection site; big red area in a weird shape at injection site; warm to touch at injection site; bad headache; very tired; nausea; not feeling like myself; possible low-grade fever; worsening soreness and pain at injection site; arm felt a little sore, as the night went on my harm was becoming more and more painful; didn't sleep well; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm felt a little sore, as the night went on my harm was becoming more and more painful), SLEEP DISORDER (didn't sleep well), HEADACHE (bad headache), FATIGUE (very tired) and NAUSEA (nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm felt a little sore, as the night went on my harm was becoming more and more painful), SLEEP DISORDER (didn't sleep well) and VACCINATION SITE DISCOMFORT (worsening soreness and pain at injection site). On 12-Jan-2021, the patient experienced HEADACHE (bad headache), FATIGUE (very tired), NAUSEA (nausea), FEELING ABNORMAL (not feeling like myself) and PYREXIA (possible low-grade fever). On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (big red area in a weird shape at injection site) and VACCINATION SITE WARMTH (warm to touch at injection site). On 12-Jan-2021, PYREXIA (possible low-grade fever) had resolved. On 13-Jan-2021, FATIGUE (very tired), NAUSEA (nausea) and FEELING ABNORMAL (not feeling like myself) had resolved. At the time of the report, PAIN IN EXTREMITY (arm felt a little sore, as the night went on my harm was becoming more and more painful), SLEEP DISORDER (didn't sleep well), HEADACHE (bad headache), VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (big red area in a weird shape at injection site), VACCINATION SITE WARMTH (warm to touch at injection site) and VACCINATION SITE DISCOMFORT (worsening soreness and pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: itchiness at injection site; big red area in a weird shape at injection site; warm to touch at injection site; bad headache; very tired; nausea; not feeling like myself; possible low-grade fever; worsening soreness and pain at injection site; arm felt a little sore, as the night went on my harm was becoming more and more painful; didn't sleep well; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm felt a little sore, as the night went on my harm was becoming more and more painful), SLEEP DISORDER (didn't sleep well), HEADACHE (bad headache), FATIGUE (very tired) and NAUSEA (nausea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm felt a little sore, as the night went on my harm was becoming more and more painful), SLEEP DISORDER (didn't sleep well) and VACCINATION SITE DISCOMFORT (worsening soreness and pain at injection site). On 12-Jan-2021, the patient experienced HEADACHE (bad headache), FATIGUE (very tired), NAUSEA (nausea), FEELING ABNORMAL (not feeling like myself) and PYREXIA (possible low-grade fever). On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (big red area in a weird shape at injection site) and VACCINATION SITE WARMTH (warm to touch at injection site). On 12-Jan-2021, PYREXIA (possible low-grade fever) had resolved. On 13-Jan-2021, FATIGUE (very tired), NAUSEA (nausea) and FEELING ABNORMAL (not feeling like myself) had resolved. At the time of the report, PAIN IN EXTREMITY (arm felt a little sore, as the night went on my harm was becoming more and more painful), SLEEP DISORDER (didn't sleep well), HEADACHE (bad headache), VACCINATION SITE PRURITUS (itchiness at injection site), VACCINATION SITE ERYTHEMA (big red area in a weird shape at injection site), VACCINATION SITE WARMTH (warm to touch at injection site) and VACCINATION SITE DISCOMFORT (worsening soreness and pain at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Lymph node pain, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: Fever (102); body aches; Bruise at the injection; Tender at injection; Large tender lymph node of axilla area with swelling; Large tender lymph node of axilla area with swelling; flu like symptoms; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PYREXIA (Fever (102)), PAIN (body aches), VACCINATION SITE BRUISING (Bruise at the injection), VACCINATION SITE PAIN (Tender at injection) and LYMPHADENOPATHY (Large tender lymph node of axilla area with swelling) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gadolinium deposition disease and Raynaud's phenomenon. Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR  XR) and VITAMIN D NOS (VITAMIN D) for an unknown indication.    On 19-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021 at 6:00 AM, the patient experienced PYREXIA (Fever (102)), PAIN (body aches), VACCINATION SITE BRUISING (Bruise at the injection), VACCINATION SITE PAIN (Tender at injection), LYMPHADENOPATHY (Large tender lymph node of axilla area with swelling), LYMPH NODE PAIN (Large tender lymph node of axilla area with swelling) and INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, PYREXIA (Fever (102)), PAIN (body aches), VACCINATION SITE BRUISING (Bruise at the injection), VACCINATION SITE PAIN (Tender at injection), LYMPHADENOPATHY (Large tender lymph node of axilla area with swelling), LYMPH NODE PAIN (Large tender lymph node of axilla area with swelling) and INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site pain
Clinical narrative: Fever (102); body aches; Bruise at the injection; Tender at injection; Large tender lymph node of axilla area with swelling; Large tender lymph node of axilla area with swelling; flu like symptoms; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PYREXIA (Fever (102)), PAIN (body aches), VACCINATION SITE BRUISING (Bruise at the injection), VACCINATION SITE PAIN (Tender at injection) and LYMPHADENOPATHY (Large tender lymph node of axilla area with swelling) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gadolinium deposition disease and Raynaud's phenomenon. Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR  XR) and VITAMIN D NOS (VITAMIN D) for an unknown indication.    On 19-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021 at 6:00 AM, the patient experienced PYREXIA (Fever (102)), PAIN (body aches), VACCINATION SITE BRUISING (Bruise at the injection), VACCINATION SITE PAIN (Tender at injection), LYMPHADENOPATHY (Large tender lymph node of axilla area with swelling), LYMPH NODE PAIN (Large tender lymph node of axilla area with swelling) and INFLUENZA LIKE ILLNESS (flu like symptoms). At the time of the report, PYREXIA (Fever (102)), PAIN (body aches), VACCINATION SITE BRUISING (Bruise at the injection), VACCINATION SITE PAIN (Tender at injection), LYMPHADENOPATHY (Large tender lymph node of axilla area with swelling), LYMPH NODE PAIN (Large tender lymph node of axilla area with swelling) and INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: felt something itchy,; there was a round site and it was pinkish,; swollen but very very little,; sores the same thing as if got a flu shot; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (felt something itchy,), INJECTION SITE ERYTHEMA (there was a round site and it was pinkish,), INJECTION SITE SWELLING (swollen but very very little,) and INJECTION SITE PAIN (sores the same thing as if got a flu shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PRURITUS (felt something itchy,), INJECTION SITE ERYTHEMA (there was a round site and it was pinkish,), INJECTION SITE SWELLING (swollen but very very little,) and INJECTION SITE PAIN (sores the same thing as if got a flu shot). At the time of the report, INJECTION SITE PRURITUS (felt something itchy,), INJECTION SITE ERYTHEMA (there was a round site and it was pinkish,), INJECTION SITE SWELLING (swollen but very very little,) and INJECTION SITE PAIN (sores the same thing as if got a flu shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Muscle spasms
Clinical narrative: lower extremity cramps; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (lower extremity cramps) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 20-Jan-2021, the patient experienced MUSCLE SPASMS (lower extremity cramps). At the time of the report, MUSCLE SPASMS (lower extremity cramps) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: my left arm hurt; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (my left arm hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (my left arm hurt). At the time of the report, PAIN IN EXTREMITY (my left arm hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Pruritus, Vaccination site erythema
Clinical narrative: It was swelling; 4 inches by 4 inches red; arm started to be sore; arm started to be sore and itchy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm started to be sore), PRURITUS (arm started to be sore and itchy), PERIPHERAL SWELLING (It was swelling) and VACCINATION SITE ERYTHEMA (4 inches by 4 inches red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm started to be sore) and PRURITUS (arm started to be sore and itchy). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (4 inches by 4 inches red). On an unknown date, the patient experienced PERIPHERAL SWELLING (It was swelling). At the time of the report, PAIN IN EXTREMITY (arm started to be sore), PRURITUS (arm started to be sore and itchy), PERIPHERAL SWELLING (It was swelling) and VACCINATION SITE ERYTHEMA (4 inches by 4 inches red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash
Clinical narrative: rash below the injection site; the site was a little itchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (rash below the injection site) and INJECTION SITE PRURITUS (the site was a little itchy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013120A or 013W0A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced INJECTION SITE RASH (rash below the injection site) and INJECTION SITE PRURITUS (the site was a little itchy). At the time of the report, INJECTION SITE RASH (rash below the injection site) and INJECTION SITE PRURITUS (the site was a little itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Eye disorder, Eye irritation, Eye pruritus, Lacrimation increased
Clinical narrative: eyes still look terrible; eyes watering; eyes itch; eyes are on fire; This spontaneous case was reported by a consumer and describes the occurrence of EYE IRRITATION (eyes are on fire), EYE DISORDER (eyes still look terrible), LACRIMATION INCREASED (eyes watering) and EYE PRURITUS (eyes itch) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced EYE IRRITATION (eyes are on fire). On an unknown date, the patient experienced EYE DISORDER (eyes still look terrible), LACRIMATION INCREASED (eyes watering) and EYE PRURITUS (eyes itch). At the time of the report, EYE IRRITATION (eyes are on fire), EYE DISORDER (eyes still look terrible), LACRIMATION INCREASED (eyes watering) and EYE PRURITUS (eyes itch) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling hot, Nausea, Pain in extremity, Somnolence
Clinical narrative: Feeling tired; Groggy; Sore arm; Nauseated; Warm; feel like zombie; This spontaneous case was reported by a health care professional and describes the occurrence of FATIGUE (Feeling tired), SOMNOLENCE (Groggy), PAIN IN EXTREMITY (Sore arm), NAUSEA (Nauseated) and FEELING HOT (Warm) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 20-Jan-2021, the patient experienced FATIGUE (Feeling tired), SOMNOLENCE (Groggy), PAIN IN EXTREMITY (Sore arm), NAUSEA (Nauseated), FEELING HOT (Warm) and VACCINATION COMPLICATION (feel like zombie). At the time of the report, FATIGUE (Feeling tired), SOMNOLENCE (Groggy), PAIN IN EXTREMITY (Sore arm), NAUSEA (Nauseated), FEELING HOT (Warm) and VACCINATION COMPLICATION (feel like zombie) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Feeling tired; Groggy; Sore arm; Nauseated; Warm; feel like zombie; This spontaneous case was reported by a health care professional and describes the occurrence of FATIGUE (Feeling tired), SOMNOLENCE (Groggy), PAIN IN EXTREMITY (Sore arm), NAUSEA (Nauseated) and FEELING HOT (Warm) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 20-Jan-2021, the patient experienced FATIGUE (Feeling tired), SOMNOLENCE (Groggy), PAIN IN EXTREMITY (Sore arm), NAUSEA (Nauseated), FEELING HOT (Warm) and VACCINATION COMPLICATION (feel like zombie). At the time of the report, FATIGUE (Feeling tired), SOMNOLENCE (Groggy), PAIN IN EXTREMITY (Sore arm), NAUSEA (Nauseated), FEELING HOT (Warm) and VACCINATION COMPLICATION (feel like zombie) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on legs and arms; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on legs and arms) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced RASH (rash on legs and arms). At the time of the report, RASH (rash on legs and arms) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: sore injection site; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore injection site) and HEADACHE (headache) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore injection site) and HEADACHE (headache). At the time of the report, VACCINATION SITE PAIN (sore injection site) and HEADACHE (headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Headache, Lymph node pain, Myalgia
Clinical narrative: Headache; Nausea; Dizziness; Fever; Muscle Aches; Diarrhea; Pain in lymph nodes; pain in arm of the injection (left arm); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to Moderna on 20-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ( ) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. The patient was treated with NAPROXEN SODIUM (ALEVE) ongoing since an unknown date for Adverse event, at a dose of 220 mg x2 tabs.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        she gave consent for safety to contact her or her healthcare provider if additional information is needed. and the out come was unknown so the follow up necessary
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Pyrexia
Clinical narrative: Headache; Nausea; Dizziness; Fever; Muscle Aches; Diarrhea; Pain in lymph nodes; pain in arm of the injection (left arm); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to Moderna on 20-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ( ) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. The patient was treated with NAPROXEN SODIUM (ALEVE) ongoing since an unknown date for Adverse event, at a dose of 220 mg x2 tabs.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        she gave consent for safety to contact her or her healthcare provider if additional information is needed. and the out come was unknown so the follow up necessary
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Peripheral swelling
Clinical narrative: Swelling on her left arm; Tingling on the right side of her face; A spontaneous report was received from a health care professional concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced peripheral swelling and paraesthesia.   The patient's medical history included bell's palsy and hemiated disk on patients neck. No relevant concomitant medications were reported.   On Date DD-jan-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, the patient experienced the events swelling on left arm and tingling on right side of her face.   Laboratory details if provided.   No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date, the outcome of the events swelling on left arm and tingling on right side of her face was unknown.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Fatigue, Headache, Nausea
Clinical narrative: tidiness of chest; headache; tired; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (tidiness of chest), HEADACHE (headache), FATIGUE (tired) and NAUSEA (nausea) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced CHEST DISCOMFORT (tidiness of chest), HEADACHE (headache), FATIGUE (tired) and NAUSEA (nausea). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (tidiness of chest), HEADACHE (headache), FATIGUE (tired) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Little diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Little diarrhea) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced DIARRHOEA (Little diarrhea). On 20-Jan-2021, DIARRHOEA (Little diarrhea) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included cholesterol medication, and medication for relaxing (not specified).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: warm to touch injection site; itchy injection site; red injection site; This spontaneous case was reported by a nurse and describes the occurrence of   in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No conmeds were provided.  Treatment  information was unknown.    Reporter did not allow further contact; Sender's Comments: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Myalgia, Nausea
Clinical narrative: Feels like he has the covid virus; Dizziness; Headache; Muscle ache; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Feels like he has the covid virus), DIZZINESS (Dizziness), HEADACHE (Headache), MYALGIA (Muscle ache) and CHILLS (Chills) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced SUSPECTED COVID-19 (Feels like he has the covid virus), DIZZINESS (Dizziness), HEADACHE (Headache), MYALGIA (Muscle ache), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, SUSPECTED COVID-19 (Feels like he has the covid virus), DIZZINESS (Dizziness), HEADACHE (Headache), MYALGIA (Muscle ache), CHILLS (Chills) and NAUSEA (Nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient did not receive any treatment medications.
Sex: M
Vaccine: COVID19
Symptoms: Suspected COVID-19
Clinical narrative: Feels like he has the covid virus; Dizziness; Headache; Muscle ache; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Feels like he has the covid virus), DIZZINESS (Dizziness), HEADACHE (Headache), MYALGIA (Muscle ache) and CHILLS (Chills) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced SUSPECTED COVID-19 (Feels like he has the covid virus), DIZZINESS (Dizziness), HEADACHE (Headache), MYALGIA (Muscle ache), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, SUSPECTED COVID-19 (Feels like he has the covid virus), DIZZINESS (Dizziness), HEADACHE (Headache), MYALGIA (Muscle ache), CHILLS (Chills) and NAUSEA (Nausea) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient did not receive any treatment medications.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Mobility decreased, Pain in extremity
Clinical narrative: soreness in arm; difficult to lift my arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021 at 3:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PAIN IN EXTREMITY (soreness in arm). At the time of the report, PAIN IN EXTREMITY (soreness in arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On 16-Jan-2021, the patient experienced mobility decreased (difficult to lift my arm). At the time of the report, mobility decreased (difficult to lift my arm) was resolving.    On 17-Jan-2021, the patient reported that pain scale was 6 out of 10. By 18-Jan-2021, it had turned way down to about 3/10 and on 20-Jan-2021, pain was at 0.5/10. Concomitant medications were not provided. Treatment information was not reported.   This case was linked to MOD-2021-076657 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: injection site is red; injection site is swollen; arm began to itch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (arm began to itch), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (arm began to itch). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen). At the time of the report, VACCINATION SITE PRURITUS (arm began to itch), VACCINATION SITE ERYTHEMA (injection site is red) and VACCINATION SITE SWELLING (injection site is swollen) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. The patient did not receive any treatment medications.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site mass
Clinical narrative: Little growth around injection site; Injection site is red; Injection site is hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Little growth around injection site), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE INDURATION (Injection site is hard) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012220A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE MASS (Little growth around injection site), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE INDURATION (Injection site is hard). At the time of the report, VACCINATION SITE MASS (Little growth around injection site), VACCINATION SITE ERYTHEMA (Injection site is red) and VACCINATION SITE INDURATION (Injection site is hard) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment for the events has been taken to alleviate it.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Peripheral swelling, Rash
Clinical narrative: arm started to swell; arm was hot; rash is covering 75-80% of her arm from her shoulder to elbow; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to Moderna on 22-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of   in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included cold packs and some Tylenol.  Concomitant medication was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jan-2021: No specific follow-up information recorded.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Salt craving, Vomiting
Clinical narrative: feels tired; had a craving for salt; nausea; vomit breakfast; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to Moderna on 20-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), VOMITING (vomit breakfast), FATIGUE (feels tired) and SALT CRAVING (had a craving for salt) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: TRAMADOL since an unknown date.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced NAUSEA (nausea) and VOMITING (vomit breakfast). On an unknown date, the patient experienced FATIGUE (feels tired) and SALT CRAVING (had a craving for salt). At the time of the report, NAUSEA (nausea), VOMITING (vomit breakfast), FATIGUE (feels tired) and SALT CRAVING (had a craving for salt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medication was not provided. Treatment information was not provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Injection site pain, Lymphadenopathy, Pruritus
Clinical narrative: Left armpit lymph nodes swelling; Left armpit lymph nodes itching; Whole armpit very painful; injection site was tender to the touch; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to the company on 20-Jan-2021.    This spontaneous case was reported by a nurse and describes the occurrence of LYMPHADENOPATHY (Left armpit lymph nodes swelling), PRURITUS (Left armpit lymph nodes itching), AXILLARY PAIN (Whole armpit very painful) and INJECTION SITE PAIN (injection site was tender to the touch) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concurrent medical conditions included Latex allergy.    On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 11-Jan-2021, the patient experienced AXILLARY PAIN (Whole armpit very painful) and INJECTION SITE PAIN (injection site was tender to the touch). On 12-Jan-2021, the patient experienced LYMPHADENOPATHY (Left armpit lymph nodes swelling) and PRURITUS (Left armpit lymph nodes itching). On 13-Jan-2021, INJECTION SITE PAIN (injection site was tender to the touch) had resolved. At the time of the report, LYMPHADENOPATHY (Left armpit lymph nodes swelling), PRURITUS (Left armpit lymph nodes itching) and AXILLARY PAIN (Whole armpit very painful) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment include Benadryl.  Patient taking PCOS medications for latex allergy.   Reporter did not allow further contact
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site movement impairment, Vaccination site pain
Clinical narrative: pain in the arm; can't move arm above shoulder/Barely could move the arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to Moderna on 20-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (can't move arm above shoulder/Barely could move the arm) and VACCINATION SITE PAIN (pain in the arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided) since an unknown date.    On 19-Jan-2021 at 8:50 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 20-Jan-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (can't move arm above shoulder/Barely could move the arm). On 20-Jan-2021 at 2:00 AM, the patient experienced VACCINATION SITE PAIN (pain in the arm). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (can't move arm above shoulder/Barely could move the arm) and VACCINATION SITE PAIN (pain in the arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.  Concomitant information was not provided.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Redness at site, Arm is severely itchy, had a reaction; Redness at site, Arm is severely itchy, had a reaction; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Redness at site, Arm is severely itchy, had a reaction) and INJECTION SITE ERYTHEMA (Redness at site, Arm is severely itchy, had a reaction) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history.). Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PRURITUS (Redness at site, Arm is severely itchy, had a reaction) and INJECTION SITE ERYTHEMA (Redness at site, Arm is severely itchy, had a reaction). At the time of the report, INJECTION SITE PRURITUS (Redness at site, Arm is severely itchy, had a reaction) and INJECTION SITE ERYTHEMA (Redness at site, Arm is severely itchy, had a reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the event was Benadryl cream.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Lymphadenopathy, Vaccination site induration, Vaccination site swelling
Clinical narrative: injection site has hardened under her skin; swelling in the injection site about the size of her palm; Pain in my armpit; Lymph nodes are swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (injection site has hardened under her skin), AXILLARY PAIN (Pain in my armpit), LYMPHADENOPATHY (Lymph nodes are swollen) and VACCINATION SITE SWELLING (swelling in the injection site about the size of her palm) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no relevant medical history provided).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced AXILLARY PAIN (Pain in my armpit) and LYMPHADENOPATHY (Lymph nodes are swollen). On an unknown date, the patient experienced VACCINATION SITE INDURATION (injection site has hardened under her skin) and VACCINATION SITE SWELLING (swelling in the injection site about the size of her palm). At the time of the report, VACCINATION SITE INDURATION (injection site has hardened under her skin), AXILLARY PAIN (Pain in my armpit), LYMPHADENOPATHY (Lymph nodes are swollen) and VACCINATION SITE SWELLING (swelling in the injection site about the size of her palm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and treatment information not provided   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: NNI
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: injection site raised; injection site is red; injection site is slightly tender; This spontaneous case was reported by a nurse and describes the occurrence of   in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL ITCH) at an unspecified dose and frequency.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.    Treatment for the event included Benadryl topical solution/cream.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Insomnia
Clinical narrative: kept me up all night, my problem was not being able to sleep; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (kept me up all night, my problem was not being able to sleep) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (kept me up all night, my problem was not being able to sleep). At the time of the report, INSOMNIA (kept me up all night, my problem was not being able to sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.    No treatment information was provided.